Sulfadimethoxine Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06150 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 78 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | gout | KG + DL |
| 3 | Jeune syndrome situs inversus | KG + DL |
| 4 | heart disease | KG + DL |
| 5 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 6 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 7 | disorder of fucoglycosan synthesis | KG + DL |
| 8 | interventricular septum aneurysm | KG + DL |
| 9 | pulmonary valve disease | KG + DL |
| 10 | Laubry-Pezzi syndrome | KG + DL |
| 11 | orofacial clefting syndrome | KG + DL |
| 12 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 13 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 14 | mitral valve disease | KG + DL |
| 15 | Prinzmetal angina | KG + DL |
| 16 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 17 | brachydactyly-syndactyly syndrome | KG + DL |
| 18 | high output heart failure | KG + DL |
| 19 | osteoarthritis | KG + DL |
| 20 | symptomatic heart failure | KG + DL |
| 21 | pseudoachondroplasia | KG + DL |
| 22 | myositis fibrosa | KG + DL |
| 23 | idiopathic granulomatous myositis | KG + DL |
| 24 | female breast carcinoma | KG + DL |
| 25 | allergic asthma | KG + DL |
| 26 | tendinitis | KG + DL |
| 27 | coronary artery disease | KG + DL |
| 28 | kyphoscoliotic heart disease | KG + DL |
| 29 | heart valve disease | KG + DL |
| 30 | heart conduction disease | KG + DL |
| 31 | pulmonary hypertension | KG + DL |
| 32 | osteoarthritis susceptibility | KG + DL |
| 33 | intrinsic asthma | KG + DL |
| 34 | intracranial arteriosclerosis | KG + DL |
| 35 | anomalous left coronary artery from the pulmonary artery | KG + DL |
| 36 | myocardial ischemia | KG + DL |
| 37 | hemoglobinopathy | KG + DL |
| 38 | myocardial disorder | KG + DL |
| 39 | fibromyalgia | KG + DL |
| 40 | inclusion body myositis | KG + DL |
| 41 | postoperative ventricular dysfunction | KG + DL |
| 42 | intermittent vascular claudication | KG + DL |
| 43 | genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability | KG + DL |
| 44 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 45 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 46 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 47 | diabetic nephropathy | KG + DL |
| 48 | beta-thalassemia with other manifestations | KG + DL |
| 49 | cardiac ventricle disease | KG + DL |
| 50 | congenital anomaly of ventricular septum | KG + DL |
(Showing top 50 of 78 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.